All Type of News
Pharmaceutical industry raised R&D investment to 5%.
The Korean pharmaceutical industry has raised an ongoing investment rate for the R&D-to-sales according to the KPMA report.
The report indicated that the total sales of 37 listed drug companies in 2004 amounted to ...
Chongkundang distributes Avelox under sole agreement with Bayer.
Chonkundang made an exclusive distribution agreement for Avelox, a quinolone antibiotic, with Bayer Korea to sell exclusively in Korea starting from Jan. next year, which may give a strong power to Chonkundang's antib...
Kolmar Korea to register patent of new nano natural compounds.
Kolmar Korea has completed the patent registration of nano size of phospholipid liposome cosmetics and its manufacturing process (No. 0530880)
The patented technology of new natural nano compound and its manufactur...
Seegene strategic alliance with VWR for U.S. market entry.
Seegene Inc., a bio venture company of Korea specialized in the discovery and analysis of gene and its function, announced a strategic business alliance with VWR International on Dec. 15 for the market entry into the ...
Oscotec and KT&G jointly to develop osteoporosis drugs.
Oscotec and KT&G agreed for a joint development of OPG secretion stimulant, a new drug candidate for the treatment of osteoporosis and arthritis, and to assign its preclinical test to Quintiles, a UK clinical research...
25 new drugs registered this year.
The KFDA's 2005 new drug registration report indicated that the total 25 drugs including Choongwae's Livaro, Pfizer Korea's Lyrica capsule, Yuhan's Revanex and Dong-A's Zydenar had completed its registration, which wa...
Moracle taking free diagnosis on head skin and alopecia.
Moracle (www.moracle.co.kr), a company specialized in hair cares, invited Dr. David Schellinger from Australia a world reputed expert of IAT in the area of head skin and alopecia to provide a free consultation service...
Vichy to cooperate pharmacy cosmetic stocks to return.
Vichy company, a cosmetic company for the retail pharmacy markets, made it clear in the meeting with director Lee Sae-jin of KPA on Dec. 27 that the company would cooperate to solve the cosmetic stock problems recentl...
OTC drug markets to face a long tunnel without light.
The health registration rates of new non-prescription products this year showed only 5% out of the total number of drug registrations, which was a big contrast with a few years back at around 60%, indicating the...
Korea United to cancel 5% distribution rates for wholesalers.
Korea United Company announced that the wholesale margin at 5% next year should be cancelled.
The KPWA said on Dec. 26 that Korea United phoned to vice chairman Lee Chang-jong during the meeting of the Pharmaceutic...
